News and Events

New LOGO Comes on Stage: Amoytop Biotech Improves Its Brand Image.

On January 17, Tebao Biotech held a brand image upgrade launch ceremony in Xiamen. The company's brand visual image was fully refreshed and upgraded, and a new brand LOGO and brand upgrade promotional video were released, marking the official launch of Tebao Biotech's new brand development strategy.

Launch of New Product-Pegneugen (Telpegfilgrastim Injection)

Xiamen, China, July 1, 2023/--Xiamen Amoytop Biotech Co., Ltd. (referred to as Amoytop Biotech hereinafter) today announced that Pegneugen® (Telpegfilgrastim Injection) has been approved by National Medical Products Administration (NMPA) and is available for marketing.

Amoytop's Quality Center awarded CNAS certificate

Recently, Amoytop's Quality Center was awarded the certificate issued by China National Accreditation Service for Conformity Assessment (CNAS) (Certificate number: CNAS L4479).

PR Newswire: Clinical effect of Pegberon® (Pegylated Interferon), China's Independent Intellectual Property, has been recognized by experts